VKH
IDXX icon

Virtu KCG Holdings’s Idexx Laboratories IDXX Stock Holding History

Virtu KCG Holdings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.35M Buy
14,570
+6,214
+74% +$1.01M 0.07% 188
2017
Q1 		$1.29M Sell
8,356
-27,356
-77% -$3.77M 0.04% 543
2016
Q4 		$4.19M Buy
35,712
+28,925
+426% +$3.3M 0.1% 93
2016
Q3 		$765K Buy
6,787
+3,606
+113% +$380K 0.02% 958
2016
Q2 		$295K Buy
3,181
+293
+10% +$25.2K 0.01% 1895
2016
Q1 		$226K Buy
2,888
+123
+4% +$8.86K 0.01% 1973
2015
Q4 		$202K Buy
+2,765
New +$197K ﹤0.01% 2702
2015
Q3 		– Sell
-3,962
Closed -$254K – 3549
2015
Q2 		$254K Buy
+3,962
New +$274K ﹤0.01% 2291
2014
Q4 		– Sell
-12,046
Closed -$710K – 3946
2014
Q3 		$710K Buy
12,046
+6,256
+108% +$396K 0.01% 1314
2014
Q2 		$387K Sell
5,790
-10,402
-64% -$661K 0.01% 2245
2014
Q1 		$983K Buy
16,192
+8,102
+100% +$483K 0.01% 1249
2013
Q4 		$430K Sell
8,090
-786
-9% -$41.4K ﹤0.01% 2136
2013
Q3 		$442K Buy
+8,876
New +$427K 0.01% 2151

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Virtu KCG Holdings's IDXX Position: Q2 2017 in Review

Virtu KCG Holdings increased its Idexx Laboratories (IDXX) stake by 74% in Q2 2017, buying an estimated $1.01M and bringing the position to 14,570 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #188.

Virtu KCG Holdings first reported a position in IDXX in Q3 2013 and has held it in 13 quarters since. The position peaked at $4.19M in Q4 2016. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

  • Virtu KCG Holdings held 14,570 shares of Idexx Laboratories worth $2.35M as of Q2 2017.
  • Virtu KCG Holdings bought 6,214 Idexx Laboratories shares in Q2 2017, an estimated $1.01M.
  • Idexx Laboratories made up 0.07% of Virtu KCG Holdings's portfolio in Q2 2017, its #188 holding.
  • Virtu KCG Holdings first reported a position in Idexx Laboratories in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Idexx Laboratories position peaked at $4.19M in Q4 2016.
  • 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.